These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23243180)

  • 1. Assessment of population-based HIV RNA levels in a rural east African setting using a fingerprick-based blood collection method.
    Jain V; Liegler T; Kabami J; Chamie G; Clark TD; Black D; Geng EH; Kwarisiima D; Wong JK; Abdel-Mohsen M; Sonawane N; Aweeka FT; Thirumurthy H; Petersen ML; Charlebois ED; Kamya MR; Havlir DV;
    Clin Infect Dis; 2013 Feb; 56(4):598-605. PubMed ID: 23243180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in population HIV RNA levels in Mbarara, Uganda, during scale-up of HIV antiretroviral therapy access.
    Jain V; Byonanebye DM; Liegler T; Kwarisiima D; Chamie G; Kabami J; Petersen ML; Balzer LB; Clark TD; Black D; Thirumurthy H; Geng EH; Charlebois ED; Amanyire G; Kamya MR; Havlir DV;
    J Acquir Immune Defic Syndr; 2014 Mar; 65(3):327-32. PubMed ID: 24146022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 viral load measurement in venous blood and fingerprick blood using Abbott RealTime HIV-1 DBS assay.
    Tang N; Pahalawatta V; Frank A; Bagley Z; Viana R; Lampinen J; Leckie G; Huang S; Abravaya K; Wallis CL
    J Clin Virol; 2017 Jul; 92():56-61. PubMed ID: 28531553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population levels and geographical distribution of HIV RNA in rural Ugandan and Kenyan communities, including serodiscordant couples: a cross-sectional analysis.
    Jain V; Petersen ML; Liegler T; Byonanebye DM; Kwarisiima D; Chamie G; Sang N; Black D; Clark TD; Ladai A; Plenty A; Kabami J; Ssemmondo E; Bukusi EA; Cohen CR; Charlebois ED; Kamya MR; Havlir DV;
    Lancet HIV; 2017 Mar; 4(3):e122-e133. PubMed ID: 27989576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of effectiveness of adherence counselling in reversing virological failure among patients on long-term antiretroviral therapy in rural Uganda.
    Birungi J; Cui Z; Okoboi S; Kapaata A; Munderi P; Mukajjanga C; Nanfuka M; Nyonyintono MS; Kim J; Zhu J; Kaleebu P; Moore DM
    HIV Med; 2020 Jan; 21(1):21-29. PubMed ID: 31432614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-uptake of viral load testing among people receiving HIV treatment in Gomba district, rural Uganda.
    Nakalega R; Mukiza N; Kiwanuka G; Makanga-Kakumba R; Menge R; Kataike H; Maena J; Akello C; Atuhaire P; Matovu-Kiweewa F; Ndikuno-Kuteesa C; Debem H; Mujugira A
    BMC Infect Dis; 2020 Oct; 20(1):727. PubMed ID: 33023498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successes and gaps in the HIV cascade of care of a high HIV prevalence setting in Zimbabwe: a population-based survey.
    Conan N; Coulborn RM; Simons E; Mapfumo A; Apollo T; Garone DB; Casas EC; Puren AJ; Chihana ML; Maman D
    J Int AIDS Soc; 2020 Sep; 23(9):e25613. PubMed ID: 32969602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High rates of viral suppression in adults and children with high CD4+ counts using a streamlined ART delivery model in the SEARCH trial in rural Uganda and Kenya.
    Kwarisiima D; Kamya MR; Owaraganise A; Mwangwa F; Byonanebye DM; Ayieko J; Plenty A; Black D; Clark TD; Nzarubara B; Snyman K; Brown L; Bukusi E; Cohen CR; Geng EH; Charlebois ED; Ruel TD; Petersen ML; Havlir D; Jain V
    J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21673. PubMed ID: 28770596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pooled HIV-1 RNA viral load testing for detection of antiretroviral treatment failure in Kenyan children.
    Chohan BH; Tapia K; Merkel M; Kariuki AC; Khasimwa B; Olago A; Gichohi R; Obimbo EM; Wamalwa DC
    J Acquir Immune Defic Syndr; 2013 Jul; 63(3):e87-93. PubMed ID: 23542638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral treatment for HIV in rural Uganda: two-year treatment outcomes of a prospective health centre/community-based and hospital-based cohort.
    Kipp W; Konde-Lule J; Saunders LD; Alibhai A; Houston S; Rubaale T; Senthilselvan A; Okech-Ojony J
    PLoS One; 2012; 7(7):e40902. PubMed ID: 22815862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point-of-Care Cepheid Xpert HIV-1 Viral Load Test in Rural African Communities Is Feasible and Reliable.
    Moyo S; Mohammed T; Wirth KE; Prague M; Bennett K; Holme MP; Mupfumi L; Sebogodi P; Moraka NO; Boleo C; Maphorisa CN; Seraise B; Gaseitsiwe S; Musonda RM; van Widenfelt E; Powis KM; Gaolathe T; Tchetgen Tchetgen EJ; Makhema JM; Essex M; Lockman S; Novitsky V
    J Clin Microbiol; 2016 Dec; 54(12):3050-3055. PubMed ID: 27733636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring virologic responses to antiretroviral therapy in HIV-infected adults in Kenya: evaluation of a low-cost viral load assay.
    Sivapalasingam S; Wangechi B; Marshed F; Laverty M; Essajee S; Holzman RS; Valentine F
    PLoS One; 2009 Aug; 4(8):e6828. PubMed ID: 19714253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of undetectable and suppressed viral load in HIV-infected pregnant women initiating Option B+ in Uganda: an observational study nested within a randomized controlled trial.
    Gabagaya G; Rukundo G; Amone A; Wavamunno P; Namale-Matovu J; Lubega I; Nakabiito C; Namukwaya Z; Nolan M; Malamba SS; King R; Homsy J; Fowler MG; Musoke P
    BMC Infect Dis; 2021 Sep; 21(1):907. PubMed ID: 34481464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV Viral Load Suppression in Adults and Children Receiving Antiretroviral Therapy-Results From the IeDEA Collaboration.
    Jiamsakul A; Kariminia A; Althoff KN; Cesar C; Cortes CP; Davies MA; Do VC; Eley B; Gill J; Kumarasamy N; Machado DM; Moore R; Prozesky H; Zaniewski E; Law M
    J Acquir Immune Defic Syndr; 2017 Nov; 76(3):319-329. PubMed ID: 28708808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of opportunistic illness on HIV RNA viral load and CD4+ T cell count among HIV-positive adults taking antiretroviral therapy.
    Ekwaru JP; Campbell J; Malamba S; Moore DM; Were W; Mermin J
    J Int AIDS Soc; 2013 Apr; 16(1):17355. PubMed ID: 23547778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimated Costs for Delivery of HIV Antiretroviral Therapy to Individuals with CD4+ T-Cell Counts >350 cells/uL in Rural Uganda.
    Jain V; Chang W; Byonanebye DM; Owaraganise A; Twinomuhwezi E; Amanyire G; Black D; Marseille E; Kamya MR; Havlir DV; Kahn JG
    PLoS One; 2015; 10(12):e0143433. PubMed ID: 26632823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Markov model for the effects of virological failure on HIV/AIDS progression in tuberculosis co-infected patients receiving antiretroviral therapy in a rural clinic in northern South Africa.
    Shoko C; Chikobvu D; Bessong PO
    S Afr Med J; 2020 Mar; 110(4):313-319. PubMed ID: 32657744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordant CSF/plasma HIV-1 RNA in individuals on virologically suppressive antiretroviral therapy in Western India.
    Dravid AN; Natrajan K; Kulkarni MM; Saraf CK; Mahajan US; Kore SD; Rathod NM; Mahajan US; Wadia RS
    Medicine (Baltimore); 2018 Feb; 97(8):e9969. PubMed ID: 29465595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community viral load and CD4 count distribution among people living with HIV in a South African Township: implications for treatment as prevention.
    Kranzer K; Lawn SD; Johnson LF; Bekker LG; Wood R
    J Acquir Immune Defic Syndr; 2013 Aug; 63(4):498-505. PubMed ID: 23572010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virologic response of treatment experienced HIV-infected Ugandan children and adolescents on NNRTI based first-line regimen, previously monitored without viral load.
    Kibalama Ssemambo P; Nalubega-Mboowa MG; Owora A; Serunjogi R; Kironde S; Nakabuye S; Ssozi F; Nannyonga M; Musoke P; Barlow-Mosha L
    BMC Pediatr; 2021 Mar; 21(1):139. PubMed ID: 33752636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.